| Literature DB >> 28940040 |
Lydia B Zablotska1, Nora Fenske2, Maria Schnelzer2, Sergey Zhivin3, Dominique Laurier4, Michaela Kreuzer2.
Abstract
PURPOSE: Long-term health risks of occupational exposures to uranium processing were examined to better understand potential differences with uranium underground miners and nuclear reactor workers.Entities:
Keywords: Cohort study; Gamma radiation; Radon; Risk assessment; Uranium
Mesh:
Substances:
Year: 2017 PMID: 28940040 PMCID: PMC5752750 DOI: 10.1007/s00420-017-1260-9
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Basic characteristics of the Port Hope and Wismut cohorts
| Characteristic | Port Hope ( | Wismut ( | Total | ||
|---|---|---|---|---|---|
| Male | Female | Male | Female | ||
|
| 2645 (88.2%) | 355 (11.8%) | 4161 (93.9%) | 270 (6.1%) | 7431 (100%) |
| Person-years | 82,753 (87.2%) | 12,103 (12.8%) | 163,832 (93.4%) | 11,513 (6.6%) | 270,201 |
| Lifetimea RDP exposure, WLM | |||||
| Mean (median) | 13.3 (0.41) | 4.9 (0) | 8.5 (5.2) | 7.4 (4.5) | 10.0 (3.0) |
| Range (SD) | 0–627.6 (45.9) | 0–62.7 (9.6) | 0.01–126.9 (9.7) | 0.02–44.1 (8.1%) | 0–627.6 (28.6) |
| Lifetimea gamma-ray dose, mSv | |||||
| Mean (median) | 116.3 (21.1) | 36.2 (2.6) | 30.8 (12.3%) | 31.1 (10.7) | 61.5 (13.8) |
| Range (SD) | 0–5098.8 (312.1) | 0–464.7 (69.7) | 0.03–667.4 (64.4) | 0.04–464.7 (69.7) | 0–5098.8 (197.4) |
mSv millisieverts, RDP radon decay products, WLM working level months
a Individual exposures cumulated up to the end of follow-up
Excess risk estimates and 95% confidence intervals for RDP exposures and gamma-ray doses for selected cancer and non-cancer causes of death, combined Port Hope and Wismut cohorts, men only
| Cause of death | Port Hope | Wismut | RDP exposure | Gamma-ray dose | ||||
|---|---|---|---|---|---|---|---|---|
| 1950–1999 | 1946–2008 | ERR/100 WLMa | 95% CI |
| ERR/Svc | 95% CI |
| |
| All causes of death | 2641 | 4161 | ||||||
| Solid cancer | 225 | 408 | 0.23 | −0.11; 0.87 | 0.27 | 0.28 | <−0.25; 1.11 | 0.32 |
| Solid cancer excluding lung cancer | 126 | 245 | 0.09 | <−0.19; 0.76 | 0.63 | 0.20 | <−0.46; 1.26 | 0.56 |
| Lung cancer | 99 | 163 | 0.68 | <−0.23; 2.45 | 0.16 | 0.43 | <−0.46; 2.13 | 0.39 |
| Larynx cancer | 5 | 8 | nc | nc | ||||
| Liver and biliary | 4 | 12 | nc | nc | ||||
| Kidney cancer | 7 | 12 | 3.48 | <−4.82; 33.7 | 0.41 | −0.19 | <0.20; 28.6 | 0.88 |
| Bladder cancer | 10 | 22 | −0.16 | <−0.16; 2.16 | 0.58 | nc | ||
| Hematological cancersd | 24 | 17 | −0.16 | <−1.23; 2.17 | 0.55 | nc | ||
| All CVD | 514 | 749 | 0.12 | −0.05; 0.36 | 0.20 | 0.13 | −0.11; 0.48 | 0.32 |
| Hypertensive disease | 13 | 36 | 0.13 | <−0.81; 3.38 | 0.82 | 0.58 | <−1.10; 5.12 | 0.49 |
| IHD | 346 | 360 | 0.17 | −0.09; 0.34 | 0.18 | 0.21 | <−0.13; 0.71 | 0.26 |
| Stroke | 71 | 181 | −0.07 | <−0.40; 0.52 | 0.72 | −0.19 | <−1.12; 0.50 | 0.39 |
| COPD | 29 | 59 | −0.16 | <−0.16; 1.41 | 0.60 | −0.19 | <−3.84; 1.40 | 0.59 |
CI confidence interval, COPD chronic obstructive pulmonary disease, CVD cardiovascular diseases, ERR/Sv excess relative risk per 1 Sv, ERR/100 WLM excess relative risk per 100 WLM, IHD ischemic heart disease, nc no convergence, RDP radon decay products
a Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. Gamma-ray doses were not included in the model
b P values from the likelihood ratio test comparing nested model with and without the exposure term
c Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. RDP exposures were not included in the model
d Includes Non-Hodgkin lymphoma, Hodgkin’s disease, multiple myeloma and leukemia
Deviances of various risks models and lag times for CVD mortality
| Exposure | Lag time, years | Deviance | ERR/100 WLMa |
|---|---|---|---|
| RDP exposure | 0 | 2737.128 | 0.12 |
| 5 | 2737.205 | 0.12 | |
| 10 | 2737.425 | 0.11 | |
| 15 | 2737.542 | 0.11 | |
| 20 | 2737.355 | 0.13 | |
| ERR/Svb | |||
| Gamma-ray doses | 0 | 2737.889 | 0.13 |
| 5 | 2737.890 | 0.13 | |
| 10 | 2738.079 | 0.12 | |
| 15 | 2738.172 | 0.12 | |
| 20 | 2738.163 | 0.13 |
CVD cardiovascular diseases, deviance −2 log likelihood of the fitted model from the maximum likelihood estimation procedure, ERR/Sv excess relative risk per 1 Sv
a Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6 + months; Port Hope cohort only) by stratification. Gamma-ray doses were not included in the model
b Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. RDP exposures were not included in the model
Relative risk estimates and 95% confidence intervals for CVD mortality by category of cumulative RDP exposure, male Port Hope and Wismut workers
| Dose categories, WLM | Mean dose, WLM | Deaths | Person-years | RRa, b | 95% CI | ||
|---|---|---|---|---|---|---|---|
| # | % | # | % | ||||
| 0–0.34 | 0.1 | 97 | 8 | 74,669 | 30 | 1 | |
| 0.35–1.09 | 1 | 106 | 8 | 26,251 | 11 | 1.45 | 1.09; 1.94 |
| 1.10–2 | 2 | 154 | 12 | 38,564 | 16 | 1.17 | 0.89; 1.53 |
| 3–7 | 5 | 272 | 22 | 47,801 | 19 | 1.49 | 1.15; 1.92 |
| 8–23 | 14 | 408 | 32 | 44,660 | 18 | 1.32 | 1.02; 1.70 |
| 24–49 | 33 | 120 | 10 | 9270 | 4 | 1.44 | 1.07; 1.94 |
| 50–99 | 68 | 59 | 5 | 2865 | 1 | 1.84 | 1.28; 2.64 |
| 100–623 | 221 | 47 | 4 | 2506 | 1 | 1.47 | 0.99; 2.20 |
| Total | 17 | 1263 | 100 | 246,586 | 100 | ||
CVD cardiovascular diseases, CI confidence interval, DOF degrees of freedom, RR relative risk, WLM working level months
a P heterogeneity ≤0.01 (DOF = 7); P linear trend 0.29 (DOF = 1)
b Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. Gamma-ray doses were not included in the model
Relative risk estimates and 95% confidence intervals for CVD mortality by category of cumulative gamma-ray doses, male Port Hope and Wismut workers
| Dose categories, Sv | Mean dose, Sv | Deaths | Person-years | RRa, b | 95% CI | ||
|---|---|---|---|---|---|---|---|
| # | % | # | % | ||||
| 0–0.00034 | 0.0001 | 20 | 2 | 42,649 | 17 | 1 | |
| 0.00035–0.0014 | 0.001 | 37 | 3 | 17,549 | 7 | 1.50 | 0.85–2.62 |
| 0.0015–0.005 | 0.003 | 113 | 9 | 34,293 | 14 | 1.46 | 0.89–2.40 |
| 0.005–0.010 | 0.007 | 129 | 10 | 35,729 | 14 | 1.27 | 0.78–2.06 |
| 0.010–0.018 | 0.014 | 148 | 12 | 27,812 | 11 | 1.66 | 1.02–2.71 |
| 0.018–0.032 | 0.022 | 212 | 17 | 32,155 | 13 | 1.45 | 0.89–2.33 |
| 0.032–0.058 | 0.044 | 206 | 16 | 22,188 | 9 | 1.39 | 0.86–2.25 |
| 0.058–0.102 | 0.077 | 130 | 10 | 12,946 | 5 | 1.69 | 1.03–2.76 |
| 0.102–0.240 | 0.147 | 106 | 8 | 11,081 | 4 | 1.54 | 0.93–2.55 |
| 0.240–0.500 | 0.334 | 85 | 7 | 5849 | 2 | 1.83 | 1.09–3.06 |
| 0.500–1.000 | 0.651 | 42 | 3 | 2692 | 1 | 1.54 | 0.87–2.72 |
| 1.000–5.097 | 1.605 | 35 | 3 | 1643 | 1 | 1.75 | 0.97–3.19 |
| Total | 0.137 | 1263 | 100 | 246,586 | 100 | ||
CVD cardiovascular diseases, CI confidence interval, DOF degrees of freedom, RR relative risk, Sv sievert
a P heterogeneity = 0.23 (DOF = 11); P linear trend = 0.53 (DOF = 1)
b Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. RDP exposures were not included in the model
Fig. 1Plot of relative risks of CVD mortality by mean RDP exposure, pooled Port Hope and Wismut cohort. The referent relative risk is 1.0
Fig. 2Plot of relative risks of CVD mortality by mean gamma-ray dose, pooled Port Hope and Wismut cohort. The referent relative risk is 1.0. The inset shows detail for dose range 0–0.15 Sv
Interaction models for CVD mortality by cumulative RDP exposure, male Port Hope and Wismut workers
| Parameter | Number of deaths | Parameter estimate and 95% CIa |
| Deviance |
|---|---|---|---|---|
| Continuous doses lagged by 5 years | 1263 | 0.12 (−0.05 to 0.35)c | 0.19 | 3521.315 |
| Continuous doses lagged by 20 years | 1263 | 0.14 (−0.05 to 0.40)c | 0.16 | 3521.128 |
| Time-window analysis | 1263 | |||
| WLM 5–14 previously | 1 | 0.62 | 3533.458 | |
| WLM 15–24 previously | 0.23 (<−0.28 to 0.99)d | |||
| WLM 25+ previously | 0.09 (−0.18 to 0.56)d | |||
| Interaction terms for time-window analyses | ||||
| Exposure rate, WLM/year (continuous) | 0.40 (0.09–1.81)e | 0.94 | ||
| Age at risk, years (continuous) | 0.96 (0.91–1.01)e | 0.99 | ||
| Age at first RDP exposure, years (continuous) | 1.00 (1.00–1.00)e | 0.96 | ||
| Duration of employment, years (continuous) | 0.76 (0.59–0.98)e | 0.01 | ||
CI confidence interval, CVD cardiovascular diseases, ERR/100 WLM excess relative risk per 100 WLM, nc no convergence, RDP radon decay products
a Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 vs. 6+ months; Port Hope cohort only) by stratification. Gamma-ray doses were not included in the model
b P values from the test of heterogeneity of category-specific relative risks
c ERR/100 WLM
d RR for time since exposure window compared to reference (exposures 5–14 years previously)
e ERR/100 WLM for time since exposure window 5–14 years and effect modifying variable
Excess risk estimates and 95% confidence intervals for RDP exposures and gamma-ray doses for selected cancer and non-cancer causes of death, combined Port Hope and Wismut cohorts, women only
| Cause of deathd | Port Hope | Wismut | RDP exposure | Gamma-ray dose | ||||
|---|---|---|---|---|---|---|---|---|
| 1950–1999 | 1952–2008 | ERR/100 WLMa | 95% CI |
| ERR/Svc | 95% CI |
| |
| All causes of death | 270 | 354 | ||||||
| Solid cancer | 24 | 24 | 1.96 | <−1.95, 10.7 | 0.36 | 2.58 | −2.79, 15.2 | 0.39 |
| Solid cancer excl lung cancer | 17 | 19 | 2.60 | <−2.08, 13.9 | 0.29 | 7.90 | <−2.38, 33.0 | 0.09 |
| Solid cancer excl colon and breast cancer | 16 | 19 | −0.43 | <−3.29, 5.85 | 0.82 | −1.10 | <−4.20, 6.89 | 0.64 |
| Lung cancer | 7 | 5 | −1.16 | <−8.93, 30.0 | 0.81 | nc | ||
| Breast cancer | 5 | 2 | 5.37 | <−10.3, 281 | 0.53 | 17.30 | <9.8, 366 | 0.22 |
| All CVD | 36 | 59 | −0.14 | <−1.79, 2.77 | 0.90 | −0.69 | <−3.12, 3.58 | 0.68 |
| IHD | 22 | 26 | 1.32 | <−1.94, 9.46 | 0.49 | 1.20 | <−3.52, 11.9 | 0.68 |
CI confidence interval, CVD cardiovascular diseases, ERR/Sv excess relative risk per 1 Sv, ERR/100 WLM excess relative risk per 100 WLM, IHD ischemic heart disease, nc no convergence, RDP radon decay products
a Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 months vs. 6+ months; Port Hope cohort only) by stratification. Gamma-ray doses were not included in the model
b P values from the likelihood ratio test comparing nested model with and without the exposure term
c Model adjusted for calendar time, age at risk, cohort and duration of employment (<6 months vs. 6+ months; Port Hope cohort only) by stratification. RDP exposures were not included in the model
d Models did not converge or had negative radiation risk estimates for all other outcomes